Cardiovirulent Coxsackieviruses and the Decay-Accelerating Factor (CD55) Receptor
- 1 May 1998
- Vol. 244 (2) , 302-314
- https://doi.org/10.1006/viro.1998.9122
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Clinical Coxsackievirus B Isolates Differ from Laboratory Strains in Their Interaction with Two Cell Surface ReceptorsThe Journal of Infectious Diseases, 1997
- An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackievirusesArchiv für die gesamte Virusforschung, 1994
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in miceArchiv für die gesamte Virusforschung, 1992
- The major human rhinovirus receptor is ICAM-1Published by Elsevier ,1989
- Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipidBiochemistry, 1986
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- Influence of sex hormones on Coxsackie B-3 virus infection in Balb/c miceCellular Immunology, 1982
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980
- Unrelated animal viruses share receptorsNature, 1976